No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...
Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.
A 31-year-old woman with stage IV breast cancer learns a test ordered more than a year before her diagnosis detected a TP53 ...
World Record Bass Dreams For dedicated bass anglers, there’s nothing quite like the dream of catching the largest bass ever recorded. Record holders join an eli ...
On Tuesday, direct-to-consumer genetic testing firm 23andMe announced it would be shuttering its much-hyped drug development ...
There’s a local program called the Gene Health Project, and the idea is to learn any bad genetic news about yourself but ...
In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...
In the wake of a big data breach and a sizable new round of layoffs, concerns about the 23andMe's handling of sensitive ...
The restructuring arrives during a period of turmoil at South San Francisco-based 23andMe, which has recently included a high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback